Cargando…
Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19
Patients hospitalised with COVID-19 have a high mortality. Identification of patients at increased risk of adverse outcome would be important, to allow closer observation and earlier medical intervention for those at risk, and to objectively guide prognosis for friends and family of affected individ...
Autores principales: | Gue, Ying X., Tennyson, Maria, Gao, Jovia, Ren, Shuhui, Kanji, Rahim, Gorog, Diana A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721695/ https://www.ncbi.nlm.nih.gov/pubmed/33288840 http://dx.doi.org/10.1038/s41598-020-78505-w |
Ejemplares similares
-
Author Correction: Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19
por: Gue, Ying X., et al.
Publicado: (2021) -
MI with Non-obstructive Coronary Artery Presenting with STEMI: A Review of Incidence, Aetiology, Assessment and Treatment
por: Gue, Ying X, et al.
Publicado: (2020) -
Fibrinolysis in Platelet Thrombi
por: Kanji, Rahim, et al.
Publicado: (2021) -
Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19
por: Gue, Ying Xuan, et al.
Publicado: (2020) -
Rationale and design of “Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)” study: A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome
por: Gue, Ying X., et al.
Publicado: (2019)